Published in Drug Metab Dispos on January 01, 1995
Chemical differentiation along metaphase chromosomes. Exp Cell Res (1968) 6.82
Identification of human chromosomes by DNA-binding fluorescent agents. Chromosoma (1970) 6.57
Neurotoxicity of a prion protein fragment. Nature (1993) 3.38
CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid. Nature (1999) 2.81
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol (2013) 2.16
Congenital and acquired thrombotic risk factors in women using oral contraceptives: clinical aspects. Clin Appl Thromb Hemost (2000) 1.99
Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem (1997) 1.97
DNA-binding fluorochromes for the study of the organization of the metaphase nucleus. Exp Cell Res (1969) 1.95
Holes and grooves: the contribution of microscopy and taphonomy to the problem of art origins. J Hum Evol (1997) 1.92
In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol (2001) 1.88
Regulation of the macrophage content of neoplasms by chemoattractants. Science (1983) 1.83
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science (1997) 1.70
Evaluation of quinacrine treatment for prion diseases. J Virol (2003) 1.59
Chemical differentiation with fluorescent alkylating agents in Vicia faba metaphase chromosomes. Exp Cell Res (1969) 1.57
Low level of circulating activated protein C is a risk factor for venous thromboembolism. Thromb Haemost (2001) 1.54
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica (2000) 1.49
Levels of PCDD/F and dioxin-like PCB in Baltic fish of different age and gender. Chemosphere (2007) 1.45
Renal perineurioma in childhood. Gen Diagn Pathol (1997) 1.44
Gene mapping by fluorescent in situ hybridization. Cell Biol Int Rep (1977) 1.42
Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res (1992) 1.40
Molecular cloning and functional characterization of brefeldin A-ADP-ribosylated substrate. A novel protein involved in the maintenance of the Golgi structure. J Biol Chem (1999) 1.39
Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab Invest (2000) 1.38
Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood (1996) 1.37
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. J Biol Chem (2000) 1.34
Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport (1993) 1.28
Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem Biophys Res Commun (1993) 1.23
Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett (2001) 1.21
p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res (1997) 1.21
Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor. Mediators Inflamm (1997) 1.21
Fluorescent labeling of chromosomal DNA: superiority of quinacrine mustard to quinacrine. Science (1970) 1.16
PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol (2000) 1.10
Pharmacokinetics of actinoymcin D in patients with malignant melanoma. Clin Pharmacol Ther (1975) 1.10
Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron. J Leukoc Biol (1989) 1.10
Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infect Immun (1986) 1.09
Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. J Mol Biol (2000) 1.09
Purification, cDNA cloning, and tissue distribution of bovine liver aldehyde oxidase. J Biol Chem (1995) 1.08
Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. J Biol Chem (1994) 1.07
Interpretation of quantitative structure-property and -activity relationships. J Chem Inf Comput Sci (2001) 1.06
Topographical amnesia. J Neurol Neurosurg Psychiatry (1977) 1.06
Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. Biochem Biophys Res Commun (1984) 1.05
IFN-beta-induced reduction of superoxide anion generation by macrophages. Immunology (1982) 1.04
Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport (1999) 1.04
Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-Prostaglandin F2alpha. J Biol Chem (1999) 1.02
Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice. Cancer Res (1985) 1.02
Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues. Int J Cancer (1985) 1.01
A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem Biophys Res Commun (1992) 1.00
N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin. Cancer Res (1975) 1.00
Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int J Cancer (1983) 0.99
Automatic karyotyping of quinacrine mustard stained human chromosomes. Exp Cell Res (1971) 0.99
High-performance liquid chromatographic separation and mass spectrometric identification of propafenone, 5-hydroxypropafenone and N-depropylpropafenone. J Chromatogr (1988) 0.98
Molybdenum(VI) salts convert the xanthine oxidoreductase apoprotein into the active enzyme in mouse L929 fibroblastic cells. Biochem J (1994) 0.98
Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Int J Cancer (1993) 0.98
Phosphatidic acid and lysophosphatidic acid induce haptotactic migration of human monocytes. J Biol Chem (1995) 0.97
A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy. Eur J Neurosci (1994) 0.97
Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts. Biochem Pharmacol (1980) 0.97
Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell line. J Neurosci Res (1998) 0.96
Membrane fluidity affects tumor-cell motility, invasion and lung-colonizing potential. Int J Cancer (1989) 0.94
Aging and food restriction: effect on lipids of cerebral cortex. Neurobiol Aging (1991) 0.94
Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Cancer Res (1998) 0.93
Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin 1 and tumor necrosis factor: a comparison with lymphotoxin and interferon. Int J Immunopharmacol (1988) 0.93
Human thymidylate synthetase--III. Effects of methotrexate and folate analogs. Biochem Pharmacol (1979) 0.93
Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity. Immunology (1983) 0.93
Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin. Am J Physiol (1998) 0.93
Kupffer cell depletion partially prevents hepatic heme oxygenase 1 messenger RNA accumulation in systemic inflammation in mice: role of interleukin 1beta. Hepatology (1998) 0.92
Animal cell mutants unable to take up biologically active glycerophospholipids. J Lipid Res (1995) 0.92
Evidence that ligand formation is a mechanism underlying the maintenance of cytochrome P-450 in rat liver cell culture. Potent maintenance by metyrapone. Biochem J (1980) 0.91
The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106--126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogen-activated protein kinase. J Biol Chem (2001) 0.90
Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram. J Neuroimmunol (2000) 0.90
Piracetam: physiological disposition and mechanism of action. Adv Neurol (1986) 0.90
Decreased half life of cyclophosphamide in patients under continual treatment. Eur J Cancer (1979) 0.90
DNA damage induced by alachlor after in vitro activation by rat hepatocytes. Toxicology (1992) 0.89
Intracellular calcium rise through L-type calcium channels, as molecular mechanism for prion protein fragment 106-126-induced astroglial proliferation. Biochem Biophys Res Commun (1996) 0.89
Inhibition of systemic inflammation by central action of the neuropeptide alpha-melanocyte- stimulating hormone. Neuroimmunomodulation (1999) 0.89
Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutation. Haematologica (2000) 0.88
Spontaneous release of interleukin-I and interleukin-6 by peripheral blood mononuclear cells after oophorectomy. Clin Sci (Lond) (1992) 0.88
Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Cancer Res (1993) 0.88
Characterization of type II intracellular IL-1 receptor antagonist (IL-1ra3): a depot IL-1ra. Eur J Immunol (1999) 0.88
High-performance liquid chromatographic determination of acetone in blood and urine in the clinical diagnostic laboratory. J Chromatogr (1991) 0.88
Cannibalism in the neolithic. Science (1986) 0.88
Assessing the environmental risks associated with contaminated sites: Definition of an Ecotoxicological Classification index for landfill areas (ECRIS). Chemosphere (2010) 0.88
Differences in cellular uptake and cytofluorescence of adriamycin and N-trifluoroacetyladriamycin-14-valerate. Cancer Res (1976) 0.87
Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res (1996) 0.87
Cloning of the cDNAs coding for two novel molybdo-flavoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase. J Biol Chem (2000) 0.87
In vivo exposure to NO2 reduces TNF and IL-6 production by endotoxin-stimulated alveolar macrophages. Am J Physiol (1996) 0.87
Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero. Ann Rheum Dis (2006) 0.87
The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 0.86
Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes. Biochem J (1996) 0.86
Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments. Mol Chem Neuropathol (1997) 0.86
Microsomal styrene mono-oxygenase and styrene epoxide hydrase activities in rats. Xenobiotica (1976) 0.86
Purification of the aldehyde oxidase homolog 1 (AOH1) protein and cloning of the AOH1 and aldehyde oxidase homolog 2 (AOH2) genes. Identification of a novel molybdo-flavoprotein gene cluster on mouse chromosome 1. J Biol Chem (2001) 0.86
Additive SMILES-based optimal descriptors in QSAR modelling bee toxicity: Using rare SMILES attributes to define the applicability domain. Bioorg Med Chem (2008) 0.86
Predictive carcinogenicity: a model for aromatic compounds, with nitrogen-containing substituents, based on molecular descriptors using an artificial neural network. J Chem Inf Comput Sci (2000) 0.85
Increased tumor necrosis factor and interleukin-6 production in the central nervous system of interleukin-10-deficient mice. Brain Res (2000) 0.85
Studies on peptide fragments of prion proteins. Adv Protein Chem (2001) 0.85
Dictyostelium cells produce platelet-activating factor in response to cAMP. Eur J Biochem (1991) 0.85
Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126. Neurobiol Dis (2000) 0.85
Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis. Gastroenterology (2001) 0.85